Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation

Sumin Kang, Shannon Elf, Shaozhong Dong, Taro Hitosugi, Ailan Guo, Hong Ruan, Sagar Lonial, Hanna Khoury, Ifor Williams, Gerard Karsenty, André Hanauer, Ting-Lei Gu, Jing Chen

Blood (2008) 112 (11): 3722.

https://doi.org/10.1182/blood.V112.11.3722.3722

Published: 2008

Journal Articles

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

Mark Girgis, Chris Hallemeier, William Blum, Randy Brown, Hsiu-san Lin, Hanna Khoury, L. Tim Goodnough, Ravi Vij, Steve Devine, Marita Wehde, Stacey Postma, Aarti Oza, John DiPersio, Douglas Adkins

Blood (2005) 105 (8): 3035–3041.

https://doi.org/10.1182/blood-2003-07-2346

Published: 2005

Journal Articles

A Dose Escalation and Phase II Study of Gemtuzumab Ozogamicin (GO) with High-Dose Cytarabine (HiDAC) for Patients (pts) with Refractory or Relapsed Acute Myeloid Leukemia (AML): CALGB 19902.

Richard M. Stone, MD, Barry Moser, PhD, Philip Schulman, MD, Robert C. Barrier, MS, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Wendy Stock, MD, Ilene A. Galinsky, NPC, Hanna Khoury, MD, Richard A. Larson, MD

Blood (2004) 104 (11): 873.

https://doi.org/10.1182/blood.V104.11.873.873

Published: 2004

Journal Articles

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Linda A. Verkruyse, MD, Aarti Oza, Steven M. Devine, MD, Douglas R. Adkins, MD, Hanna Khoury, MD, John F. DiPersio, MD, Ravi Vij, MD

Blood (2004) 104 (11): 3158.

https://doi.org/10.1182/blood.V104.11.3158.3158

Published: 2004

Journal Articles

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Peter Westervelt, Randy A. Brown, Douglas R. Adkins, Hanna Khoury, Peter Curtin, David Hurd, Selina M. Luger, Margaret K. Ma, Timothy J. Ley, John F. DiPersio

Blood (2001) 98 (2): 266–271.

https://doi.org/10.1182/blood.V98.2.266

Published: 2001

Journal Articles

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Douglas R. Adkins, Lawrence T. Goodnough, Shalini Shenoy, Randy Brown, Jennifer Moellering, Hanna Khoury, Ravi Vij, John DiPersio

Blood (2000) 95 (11): 3605–3612.

https://doi.org/10.1182/blood.V95.11.3605

Published: 2000

NARROW

FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

A Dose Escalation and Phase II Study of Gemtuzumab Ozogamicin (GO) with High-Dose Cytarabine (HiDAC) for Patients (pts) with Refractory or Relapsed Acute Myeloid Leukemia (AML): CALGB 19902.

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

FGFR3 Associates with and Tyrosine-Phosphorylates p90RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

A Dose Escalation and Phase II Study of Gemtuzumab Ozogamicin (GO) with High-Dose Cytarabine (HiDAC) for Patients (pts) with Refractory or Relapsed Acute Myeloid Leukemia (AML): CALGB 19902.

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor–mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only